dexlansoprazole takeda 60 milligram capsules modified release
takeda pharma a/s - dexlansoprazole - capsules modified release - 60 milligram
dexilant 30 mg
takeda israel ltd - dexlansoprazole - modified release capsules - dexlansoprazole 30 mg - dexlansoprazole - dexilant 30 is indicated in adults and in adolescents aged 12 to 17 years for the following:• maintenance of healed erosive reflux oesophagitis and maintenance of relief of heartburn• short-term treatment of heartburn and acid regurgitation associated with symptomatic non-erosive gastro-oesophageal reflux disease (gord).
dexilant 60 mg
takeda israel ltd - dexlansoprazole - modified release capsules - dexlansoprazole 60 mg - dexlansoprazole - dexilant 60 is indicated in adults and in adolescents aged 12 to 17 years for the following:• treatment of erosive reflux oesophagitis
adcetris 50 mg
takeda israel ltd - brentuximab vedotin - powder for concentrate for solution for infusion - brentuximab vedotin 50 mg/vial - brentuximab vedotin - adcetris is indicated for the treatment of adult patients with relapsed or refractory cd30+ hodgkin lymphoma (hl): 1. following autologous stem cell transplant (asct) or 2. following at least two prior therapies when asct or multi-agent chemotherapy is not a treatment option. adcetris is indicated for the treatment of adult patients with relapsed or refractory systemic anaplastic large cell lymphoma (salcl). adcetris is indicated for the treatment of adult patients with cd30+ hl at increased risk of relapse or progression following asct. adcetris is indicated for the treatment of adult patients with cd30+ cutaneous t-cell lymphoma (ctcl) after at least 1 prior systemic therapy . adcetris is indicated for the treatment of adult patients with previously untreated stage iii or iv classical hodgkin lymphoma (chl), in combination with doxorubicin, vinblastine, and dacarbazine.adcetris is indicated for the treatment of adult patients with previously untreated systemic anaplastic large cell lymphoma (salcl) or other cd30-expressing peripheral t-cell lymphomas (ptcl), including angioimmunoblastic t-cell lymphoma and ptcl not otherwise specified, in combination with cyclophosphamide, doxorubicin, and prednisone.
human albumin 200g-i takeda solution
takeda manufacturing ag, austria - albumin human - solution - 20 %
human albumin 50g-i takeda 250ml solution
takeda manufacturing ag, austria - albumin human - solution - 5 %
factor vii takeda 600 ui/vial polvo liofilizado para solución inyectable + solvente i.v.
takeda manufacturing austria ag - factor vii - factor vii....600 ui / agua inyectable....10 ml
adcetris 50mg powder for concentrate for solution for infusion vials
takeda uk ltd - brentuximab vedotin - powder for solution for infusion - 50mg
entyvio 300mg powder for concentrate for solution for infusion vials
takeda uk ltd - vedolizumab - powder for solution for infusion - 300mg
mepact 4mg powder for suspension for infusion vials
takeda uk ltd - mifamurtide - powder for suspension for infusion - 4mg